0001613103-23-000076.txt : 20230802
0001613103-23-000076.hdr.sgml : 20230802
20230802195329
ACCESSION NUMBER: 0001613103-23-000076
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20230731
FILED AS OF DATE: 20230802
DATE AS OF CHANGE: 20230802
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Salmon Sean
CENTRAL INDEX KEY: 0001792380
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-36820
FILM NUMBER: 231137625
MAIL ADDRESS:
STREET 1: MEDTRONIC PLC, 710 MEDTRONIC PARKWAY
STREET 2: LC300
CITY: MINNEAPOLIS
STATE: MN
ZIP: 55432
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Medtronic plc
CENTRAL INDEX KEY: 0001613103
STANDARD INDUSTRIAL CLASSIFICATION: ELECTROMEDICAL & ELECTROTHERAPEUTIC APPARATUS [3845]
IRS NUMBER: 000000000
FISCAL YEAR END: 0427
BUSINESS ADDRESS:
STREET 1: 20 ON HATCH, LOWER HATCH STREET
CITY: DUBLIN
STATE: L2
ZIP: 2
BUSINESS PHONE: 01135314381700
MAIL ADDRESS:
STREET 1: 20 ON HATCH, LOWER HATCH STREET
CITY: DUBLIN
STATE: L2
ZIP: 2
FORMER COMPANY:
FORMER CONFORMED NAME: Medtronic Ltd
DATE OF NAME CHANGE: 20150112
FORMER COMPANY:
FORMER CONFORMED NAME: Medtronic Holdings Ltd
DATE OF NAME CHANGE: 20140711
FORMER COMPANY:
FORMER CONFORMED NAME: Kalani I Ltd
DATE OF NAME CHANGE: 20140709
4
1
wk-form4_1691020401.xml
FORM 4
X0508
4
2023-07-31
0
0001613103
Medtronic plc
MDT
0001792380
Salmon Sean
710 MEDTRONIC PARKWAY
MINNEAPOLIS
MN
55432
0
1
0
0
EVP & President Cardiovascular
0
Ordinary Shares
2023-07-31
4
A
0
9686
0
A
46290
D
Performance Share Units
2023-07-31
4
A
0
21214
0
A
Performance Share Unit
21214
21214
D
Stock Option (Right to Buy)
87.76
2023-07-31
4
A
0
68196
0
A
2033-07-31
Ordinary Shares
68196
68196
D
Restrictions on the award shall lapse 100% on the third anniversary of the Grant Date.
Includes 516 units acquired through dividend reinvestment since the last report filed by the reporting person.
Each performance share unit represents a contingent right to receive one share of Medtronic common stock.
The number of shares to be issued in connection with the performance share units ("PSUs") will vary depending on the level of certain performance metrics achieved over a three (3) year performance period. If target performance metrics are achieved, 21,214 shares will be issued. If maximum performance metrics are achieved, 48,428 shares will be issued. If minimum performance metrics are not met, such PSUs may vest at 0 shares.
Vests on July 31, 2026.
These options become exercisable at the rate of 25% of the shares granted beginning on the first anniversary of the grant.
/s/ Thomas L. Osteraas, attorney-in-fact
2023-08-02